Auris Medical Holding Ltd. Share Price Börse Stuttgart
Equities
2QAA
BMG070252017
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 29.78L 33.2L 30.74L 28Cr |
---|---|---|---|---|---|
Net income 2024 * | -70L -78.06L -72.26L -65Cr | Net income 2025 * | -1Cr -1.12Cr -1.03Cr -93Cr | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.34
x | P/E ratio 2025 * |
-0.46
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.11% |
Latest transcript on Auris Medical Holding Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/03/01 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01/21/01 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01/18/01 |
Mats Blom
BRD | Director/Board Member | 59 | 01/17/01 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/03/01 |
1st Jan change | Capi. | |
---|---|---|
+18.94% | 13TCr | |
+14.52% | 11TCr | |
-4.61% | 2.46TCr | |
+3.23% | 2.28TCr | |
-10.44% | 1.82TCr | |
-41.74% | 1.65TCr | |
-12.56% | 1.65TCr | |
+2.66% | 1.34TCr | |
+28.24% | 1.11TCr |